---
schema_version: "secwatch.filing_event.v1"
accession: "0002001557-26-000192"
form_type: "8-K"
ticker: "INV"
cik: "0002001557"
company_name: "Innventure, Inc."
filed_at: "2026-10-08T12:21:39+00:00"
generated_at: "2026-10-12T15:37:16.369944+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Innventure launches $60M at-the-market equity program, ends YA II standby equity agreement

## Summary
- ATM permits sales of Innventure common stock up to $60M aggregate; company is under no obligation to sell, with sales expected over an extended period at its discretion.
- Company discontinued the standby equity purchase agreement with YA II PN, Ltd. entered in October 2023, after becoming eligible to use a Form S-3 shelf registration statement.
- An independent and disinterested Board committee monitors ATM parameters; Chairman Bruce Brown said the ATM gives the Board flexibility to control the timing and extent of dilution.
- CEO Dr. Bill Grieco said proceeds support operations and ongoing development of Accelsius, alongside a significant reduction in parent-company costs.

## SEC filing metadata
- accession: 0002001557-26-000192
- form_type: 8-K
- ticker: INV
- cik: 0002001557
- company_name: Innventure, Inc.
- filed_at: 2026-10-08T12:21:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2001557/000200155726000192/0002001557-26-000192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2001557/000200155726000192/innv-20261008.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002001557-26-000192
- JSON: https://secwatch.observer/filing/0002001557-26-000192.json
- Plain text: https://secwatch.observer/filing/0002001557-26-000192.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.